Gm Pete

#AZN

Healthcare •Drug Manufacturers – General• United Kingdom• NASD

Healthcare # 3 for month | #3 for the week.

Three day pause, Resistance at $78, Next resistance at 88, then all time , lots of room to go after,

Price action has been good, Single moving averages in harmony, volume has been good ( light volume pause )Rel…

Read more

finance.yahoo.com

AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China

On Thursday, AstraZeneca Plc (NASDAQ:AZN) reported fourth-quarter sales of $14.89 billion, up 18% year over year (+19% at constant currency), beating the consensus of $14.29 billion. The company's adjusted EPADS reached $1.04, beating the consensus of $1.03. The adjusted EPS … Continue reading

Gm

# MO

Consumer Defensive.• Tobacco• USA• NYSE

Consumer Defensive # 1 for the month # 3 for the week

Relative strength , 4 Day Pause, Stock respects the 10 Sma , Major Resistance at $58 with the next resistance at $65 .. Price action has been good… Single Move Average Harmony…… Volume has been good……. light volume during pause

(Two for one risk…

Read more

finance.yahoo.com

Altria Group Inc (MO) Q4 2024 Earnings Call Highlights: Strong Financial Performance Amid ...

Altria Group Inc (MO) reports robust earnings growth and shareholder returns, while navigating the complexities of the illicit e-vapor market.

Gm Pete

# Gild

Healthcare •Drug Manufacturers – General •USA•NASD

Healthcare # 3 For the month # 2 for the week .

Relative strength , 3 Day Pause, Sock respect the 10 Sma , Resistance at $117 with the next resistance at $120 .. Price action has been good… Single Move Average Harmony…… Volume has been good……. light volume during…

Read more

finance.yahoo.com

Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.4% year on year to $7.57 billion. The company expects the full year’s revenue to be around $28.4 billion, close to analysts’ … Continue reading

Gm Pete

# EXEL

Healthcare• Biotechnology• USA• NASD

Healthcare # 3 for month | #3 for the week.

IND, Resistance at $38, then all time , lots of room to go after,

Price action has been good, Single moving averages in harmony, volume has been good ( light volume pause )Rel Volume 1.15

Risking $1.36 to earn $5 , (Average moves) $4 – $5…

Read more

finance.yahoo.com

Exelixis (EXEL) Q4 Earnings and Revenues Top Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of 7.84% and 0.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Gm Pete

# CCEP

Consumer Defensive •Beverages – Non-Alcoholic• United Kingdom. NASD

Consumer Defensive # 1 for the month .

Relative strength , three week Pause, Resistance at $87.50, then All time high…..

Price action has been good… Single Move Average Harmony…… Volume has been good……. light volume during pause

Risking $2.01 earn $7, ( Average…

Read more

Pete

Thanks for all you do !!!

# WMT

I have this stock in my watchlist, I wanted to get in after earning.

Stock went to $92 which was the support. The next candle stock rallied which would be the optimal entry.

I normally wait until the stock goes over the opening price for the month $98.25 or the candle close on the opposite side of the…

Read more

Gm

# AEP

Utilities •Utilities – Regulated Electric• USA•NASD

Utilities # 3 for the month

Relative strength, four day pause,

Stock has respected the 10 Sma and is sitting on the 10 Sma , Resistance at $107, then all time , lots of room to go ,

Price action has been good, Single moving averages in harmony, volume has been good ( light volume pause )…

Read more

#Way

Healthcare• Health Information Services• USA•NASD

Healthcare # 6 for month | #3 for the week.

Relative strength, IND, (week ) , One day late on the optimal entry,

Stock has respected the 20 Sma + sitting on the 20 Sma , Resistance at $46, then all time , lots of room to go ,

Price action has been good, Single moving averages in…

Read more

finance.yahoo.com

Waystar Holding Corp (WAY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Waystar Holding Corp (WAY) reports an 18% revenue increase in Q4 2024, driven by strategic innovations and a successful IPO, despite facing challenges in maintaining profitability.

Gm

# Gild

Healthcare •Drug Manufacturers – General •USA•NASD

Healthcare # 2 for the week .

Relative strength ,4 Day Pause, Sock respect the 10 Sma , Resistance at $112 with the next resistance at $120 .. Price action has been good… Single Move Average Harmony…… Volume has been good……. light volume during pause

( 2 for 1 reward )Risking…

Read more

finance.yahoo.com

Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.4% year on year to $7.57 billion. The company expects the full year’s revenue to be around $28.4 billion, close to analysts’ … Continue reading

Gm

# Gral

Healthcare •Diagnostics & Research• USA•NASD

Healthcare # 3 for the month

IND, IND(week ) Stock has respected the 20 Sma , found support at 20 SMa $40, next resistance at $57.00 and $65 , lots of room to go , Price action has been good, Single moving averages in harmony, volume has been good ( light volume pause )Rel…

Read more

finance.yahoo.com

GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...

Despite a significant net loss, GRAIL Inc (GRAL) reports strong revenue growth and strategic collaborations, setting the stage for future advancements.